Literature DB >> 30196823

Genome-wide association study in Guillain-Barré syndrome.

Stefan Blum1, Ying Ji2, David Pennisi3, Zhixiu Li3, Paul Leo3, Pamela McCombe1, Matthew A Brown4.   

Abstract

Guillain-Barré syndrome (GBS) is considered to have an immune-mediated basis, but the genetic contribution to GBS is unclear. We conducted a GWAS involving 215 GBS patients and 1,105 healthy controls. No significant associations of individual SNPs or imputed HLA types were observed. We performed a genome-wide complex trait analysis for evaluation of the heritability of GBS, and found that common SNPs contribute up to 25% of susceptibility to the disease. Genetic risk score analysis showed no evidence of overlap in genetic susceptibility factors of GBS and multiple sclerosis. Given the unexplained heritability of the trait further larger GWAS are indicated.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Case-control study; Genetic risk score; Genome-wide association study; Guillain-Barré syndrome; Heritability; Human leukocyte antigen (HLA) genes

Mesh:

Year:  2018        PMID: 30196823     DOI: 10.1016/j.jneuroim.2018.07.016

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  3 in total

Review 1.  A review of the role of genetic factors in Guillain-Barré syndrome.

Authors:  Amin Safa; Tahereh Azimi; Arezou Sayad; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  J Mol Neurosci       Date:  2020-10-07       Impact factor: 3.444

Review 2.  Axonal variants of Guillain-Barré syndrome: an update.

Authors:  Pei Shang; Mingqin Zhu; Ying Wang; Xiangyu Zheng; Xiujuan Wu; Jie Zhu; Jiachun Feng; Hong-Liang Zhang
Journal:  J Neurol       Date:  2020-03-05       Impact factor: 4.849

3.  A missense mutation in the MLKL brace region promotes lethal neonatal inflammation and hematopoietic dysfunction.

Authors:  Joanne M Hildebrand; Maria Kauppi; Ian J Majewski; Zikou Liu; Allison J Cox; Sanae Miyake; Emma J Petrie; Michael A Silk; Zhixiu Li; Maria C Tanzer; Gabriela Brumatti; Samuel N Young; Cathrine Hall; Sarah E Garnish; Jason Corbin; Michael D Stutz; Ladina Di Rago; Pradnya Gangatirkar; Emma C Josefsson; Kristin Rigbye; Holly Anderton; James A Rickard; Anne Tripaydonis; Julie Sheridan; Thomas S Scerri; Victoria E Jackson; Peter E Czabotar; Jian-Guo Zhang; Leila Varghese; Cody C Allison; Marc Pellegrini; Gillian M Tannahill; Esme C Hatchell; Tracy A Willson; Dina Stockwell; Carolyn A de Graaf; Janelle Collinge; Adrienne Hilton; Natasha Silke; Sukhdeep K Spall; Diep Chau; Vicki Athanasopoulos; Donald Metcalf; Ronald M Laxer; Alexander G Bassuk; Benjamin W Darbro; Maria A Fiatarone Singh; Nicole Vlahovich; David Hughes; Maria Kozlovskaia; David B Ascher; Klaus Warnatz; Nils Venhoff; Jens Thiel; Christine Biben; Stefan Blum; John Reveille; Michael S Hildebrand; Carola G Vinuesa; Pamela McCombe; Matthew A Brown; Benjamin T Kile; Catriona McLean; Melanie Bahlo; Seth L Masters; Hiroyasu Nakano; Polly J Ferguson; James M Murphy; Warren S Alexander; John Silke
Journal:  Nat Commun       Date:  2020-06-19       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.